Digital Product · Trans-Tasman HealthTech GTM

New Zealand → Australia Scale Stack™

Your next 10X market is across the Tasman. Enter with a system.

Most NZ HealthTech startups do not fail because the product is weak. They hit a market ceiling. This product helps founders map the Australian buyers, procurement pathways, validation signals, investors, and expansion partners needed to scale beyond New Zealand.

Secure PayPal checkout · Digital PDF + database · Delivery in 5–7 business days
01
Buyer databaseIdentify Australian public, private, hospital, diagnostic and care buyers.
02
Procurement pathwaysUnderstand regulation, reimbursement, approval and purchasing friction.
03
Investor mapFind capital sources aligned with HealthTech, MedTech and digital health scale.
04
90-day roadmapMove from random outreach to structured Australia expansion execution.
Trans-Tasman Expansion Dashboard
Interactive preview of the logic inside the product
€297
5.3MNZ population and limited local scaling ceiling
27M+Australia population and larger buyer base
Approx. larger addressable population market

Expansion Layer Preview

Select a layer to see where founders usually lose time before entering Australia.

DifficultyModerate–High
Main blockerWrong first buyer segment
Proof neededClinical + commercial ROI
Best movePrioritize buyer fit first
What You Receive

Not just a map. A practical Australia entry decision system.

Built for NZ HealthTech founders, investors and commercialization teams that need to move beyond ecosystem awareness into buyer targeting, procurement readiness and partner-led scale.

🧭

Scale Stack Visual

High-impact square map covering NZ Innovation, NZ Validation, Australia Buyers, Procurement & Regulation, and Investors & Capital.

🏥

Buyer Database

Target Australian public health systems, private hospital groups, diagnostics, aged care, digital health and care delivery buyers.

📋

Procurement Guide

Understand the regulatory, reimbursement, safety, digital health and purchasing layers that delay Australian expansion.

📊

Readiness Diagnostic

Score buyer readiness, validation strength, procurement readiness, capital readiness and partner readiness.

💰

Investor Map

Identify Australian and trans-Tasman capital sources relevant to HealthTech, MedTech, Clinical AI and digital health scale.

🚀

90-Day Playbook

Step-by-step first 90 days for validating the market, targeting buyers, shaping outreach and avoiding wasted motion.

Interactive ROI Logic

How much upside is trapped by staying NZ-only?

If Australia is 5× larger by population, even modest conversion can create a meaningful expansion case. Use this calculator to estimate the revenue opportunity and cost of delayed entry.

Current NZ annual revenue€250k
Expected AU conversion vs NZ35%
Months delayed without clear entry plan9 months
Monthly expansion burn€20k
Estimated AU revenue upside€438k
Delay runway cost€180k
Total opportunity case€618k
Product payback multiple2,081×
Why Buy This

Cheaper than one week of wrong-market outreach.

Founder Need Scale Stack™ DIY Research Consulting Sprint
Australia buyer targetingIncludedFragmentedUsually custom
Procurement & regulation overviewIncludedHard to structureIncluded if scoped
Investor and capital mapIncludedTime-consumingOften extra
Expansion readiness diagnosticIncludedNot structuredCustom
90-day Australia entry roadmapIncludedUsually missingCustom
Time to usable output5–7 business days2–6 weeks1–3 weeks
Cost€297Hidden founder time€3,000–€10,000+
One-time purchase · Founder-ready

Before you cross the Tasman, know who matters.

The wrong Australia entry path can cost months of runway, investor momentum and buyer confidence. This Scale Stack gives you a clearer route from NZ validation to Australian revenue.

✅ Full NZ → Australia visual map
✅ Australia buyer database
✅ Procurement & regulation guide
✅ Investor & capital map
✅ Expansion readiness diagnostic
✅ First 90-day entry playbook
Secure PayPal checkout · Delivery in 5–7 business days · GrowthVybz HealthTech Market Intelligence